Available Products

Cymra Life Sciences specially formulated chronic pain formulation. It is an oral solution of cannabis oil and is only available through prescription on the SAS Cat B. 

Product Information


Accessing Our Products ​

Our products are only available through the Therapeutic Goods Administration (TGA) Special Access Scheme (Cat B) or through the Authorised Prescriber scheme. Cymra Life Sciences can not provide medical cannabis products to individuals directly under any circumstances.

Physicians will need to submit an application under the Special Access Scheme or the Authorised Prescriber Scheme. Further information on the application process can be found on the TGA website. If you’re a physician and need help with the application process, get in touch and we can help.


Product Side Effects​

Like all prescription medicines, patients can experience possible side effects when using medical cannabis products. It’s important to speak to your doctor about the suitability of medical cannabis for the treatment of your specific condition. For more information visit our FAQ page.